POT1 and non-small cell lung carcinoma: Germline and somatic POT1 mutations and the dysregulation of POT1 expression have been detected across different cancer types, most prevalently in cutaneous melanoma and squamous cell carcinoma, angiosarcoma, non-small-cell carcinoma of the lung and chronic lymphocytic leukemia (CLL).